Cleveland-More than one study has shown that urinary incontinence is the most feared complication of radical prostatectomy, and patients have altered their lives to varying degrees following this procedure depending on their level of incontinence.
Does non-physician practice ownership reduce the quality of patient care?
The survey highlights the challenges and opportunities physicians encounter in hospital- and corporate-owned settings.
How APPs can bridge the gap in urologist shortages
In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.
Cleveland Clinic urologist to lead esteemed medical journal
Hadley Wood, MD, shares her vision as the new editor-in-chief of Urology.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
Drug extends survival in prostate cancer with genetic mutations
“Our analysis suggests that there is superior clinical benefit with olaparib versus control both in patients who had and had not received previous taxane treatment,” said Maha Hussain, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Disitamab vedotin shows promise in HER2+ metastatic urothelial carcinoma
"In these studies, we were pleased to find that disitamab vedotin has consistent efficacy and manageable safety in patients with chemotherapy-refractory mUC," says Jun Guo, MD.
2 Clarke Drive Cranbury, NJ 08512